NCT03749109 - Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 19, 2019

Primary Completion Date

June 21, 2021

Study Completion Date

July 18, 2021

Conditions

Endometriosis

Interventions

DRUG

Quinagolide 1080 µg

Vaginal ring containing Quinagolide 1080 µg for daily releases

DRUG

Placebo

Matching placebo

Trial Locations (11)

Gyneacology Rigshospitalet, Copenhagen

Charité Universitätsmedizin, Berlin

Universitätsklinikum Carl Gustav Carus, Dresden

Universitätsklinikum Münster, Münster

Azienda Opsedaliera Universitaria Careggi, Florence

Università degli Studi di Roma La Sapienza, Rome

Azienda Ospedaliera Universitaria Senese, Siena

Azienda Ospedaliera Universitaria Integrata Verona, Verona

Centrum Medyczne PROMED, Krakow

Gabinet Lekarski Specjalistyczny SONUS, Warsaw

Specjalistyczny Gabinet Lekarski, Warsaw